Deep brain stimulation (DBS) is an effective treatment for common movement disorders and has been used to modulate neural activity through delivery of electrical stimulation to key brain structures. The long-term efficacy of stimulation in treating disorders, such as Parkinson's disease and essential tremor, has encouraged its application to a wide range of neurological and psychiatric conditions. Nevertheless, adoption of DBS remains limited, even in Parkinson's disease. Recent failed clinical trials of DBS in major depression, and modest treatment outcomes in dementia and epilepsy, are spurring further development. These improvements focus on interaction with disease circuits through complementary, spatially and temporally specific approaches. Spatial specificity is promoted by the use of segmented electrodes and field steering, and temporal specificity involves the delivery of patterned stimulation, mostly controlled through disease-related feedback. Underpinning these developments are new insights into brain structurefunction relationships and aberrant circuit dynamics, including new methods with which to assess and refine the clinical effects of stimulation. Deep brain stimulation (DBS) is an effective treatment strategy for a wide range of neurological conditions, such as Parkinson's disease 1-4 , essential tremor 5,6 , and dystonia 7-10. Prior expertise gained from surgical ablation strongly influenced the clinical use of DBS-in particular, the choice of brain regions targeted for stimulation 11,12. Empirically chosen stimulation parameters (e.g., a 130-180 Hz stimulation frequency, a 60-90 μs pulse width, and 1-4 V stimulation intensity) 6 induce similar clinical outcomes to those observed with surgical ablation. Long-term efficacy of applying high-frequency stimulation to certain brain regions 5 , together with the reversible nature of DBS and the